|Skip left side navigation and go to content||
PGRN: Pharmacogenomics Research Network
This program is in collaboration with NIGMS, as well as other secondary institutions including NHGRI, NCI, NIAMS, NICHD, NIDA, NIMH, and OWHR. The program was designed to support multidisciplinary, collaborative research groups to study how genetic variation contributes to interindividual differences in responses to medications. The PGRN includes 14 scientific research projects and seven network resources. The Pharmacogenetics Knowledgebase (PharmGKB) has been established to integrate information obtained from pharmacogenomics, phenotypes, and genotypes. The NHLBI currently supports four studies under this RFA to investigate the pharmacogenetics of heart, lung, and blood diseases and disorders.
The NHLBI Program Officer for PGRN is Dina Paltoo, Ph.D., M.P.H.
NIGMS Pharmacogenomics Research Network
Program Start and End Date
April 2000 to July 2015
Original Funding Announcements (FOA)
Pharmacogenetics Research Network and Knowledge Base
Last Updated September 2011